NURS 6630 MIDTERM EXAM QUESTIONS AND ANSWERS 2025
Noncompliance - (ANSWER)Patient refusal to follow prescribed treatment.
Neurotransmitter Imbalance - (ANSWER)Disruption in brain chemical levels affecting mood.
Positive Symptoms - (ANSWER)Symptoms that add to the patient's experience.
Agitation - (ANSWER)Increased restlessness or anxiety in schizophrenia.
Serotonin - (ANSWER)Neurotransmitter linked to mood regulation.
Prozac - (ANSWER)First antidepressant targeting serotonin imbalance.
Dysfunctioning Neurotransmitter Systems - (ANSWER)Impaired neurotransmitter functions in psychiatric
illnesses.
Gene Expression - (ANSWER)Process of converting genetic information into proteins.
Transcription Factor - (ANSWER)Protein that initiates gene transcription.
Behavior Modification - (ANSWER)Changes in behavior influencing genetic expression.
Cytochrome P450 - (ANSWER)Enzyme system affecting drug metabolism.
Bioavailability - (ANSWER)Amount of drug available after metabolism.
Pharmacokinetics - (ANSWER)Study of drug absorption, distribution, metabolism, and excretion.
Lower Drug Doses - (ANSWER)Some Asians require reduced doses of medications.
,NURS 6630 MIDTERM EXAM QUESTIONS AND ANSWERS 2025
G-Protein Linked Receptors - (ANSWER)Receptors that mediate cellular responses to neurotransmitters.
Antagonistic Traits - (ANSWER)Medications that block receptor activity.
Clozapine (Clozaril) - (ANSWER)Medication used for treatment-resistant schizophrenia.
Smoking Impact - (ANSWER)Smoking can alter medication metabolism.
Carbamazepine (Tegretol) - (ANSWER)Mood stabilizer associated with thrombocytopenia.
Mood Stabilizer - (ANSWER)Medication used to treat mood disorders.
Amitriptyline (Elavil) - (ANSWER)Antidepressant also used for chronic pain.
Fluoxetine (Prozac) - (ANSWER)SSRI antidepressant for depression and anxiety.
Drug-Induced Thrombocytopenia - (ANSWER)Low platelet count caused by medication.
Amitriptyline (Elavil) - (ANSWER)An antidepressant used for mood disorders.
Inverse agonist - (ANSWER)Decreases serotonin and dopamine activity.
Benzodiazepines - (ANSWER)Medications for anxiety and panic disorders.
Ionotropic receptors - (ANSWER)Receptors that mediate rapid synaptic transmission.
Varenicline (Chantix) - (ANSWER)Medication used for smoking cessation.
,NURS 6630 MIDTERM EXAM QUESTIONS AND ANSWERS 2025
Partial agonists - (ANSWER)Drugs that partially stimulate receptors.
Anticonvulsants - (ANSWER)Medications used to stabilize mood and treat seizures.
Ligand-gated ion channels - (ANSWER)Channels activated by neurotransmitter binding.
Sertraline - (ANSWER)An SSRI used to treat panic disorder.
Short-acting benzodiazepine - (ANSWER)Used temporarily to manage anxiety symptoms.
Mood stabilizers - (ANSWER)Medications that prevent mood swings in bipolar disorder.
MAO inhibitors - (ANSWER)Antidepressants with significant food interactions.
Fluoxetine - (ANSWER)An SSRI with uncommon sedation side effects.
Manic symptoms - (ANSWER)Signs of elevated mood and hyperactivity.
D2 receptors - (ANSWER)Dopamine receptors targeted by antipsychotics.
Tardive dyskinesia - (ANSWER)Involuntary movements from long-term antipsychotic use.
Hypertensive crisis - (ANSWER)Severe increase in blood pressure from food interactions.
Serotonin 3 receptors - (ANSWER)Receptors involved in serotonin signaling.
Nicotinic receptors - (ANSWER)Cholinergic receptors that respond to acetylcholine.
, NURS 6630 MIDTERM EXAM QUESTIONS AND ANSWERS 2025
Cholinergic receptors - (ANSWER)Receptors activated by the neurotransmitter acetylcholine.
Glycine receptors - (ANSWER)Inhibitory receptors in the central nervous system.
Dopamine agonist - (ANSWER)Stimulates dopamine receptors to treat Parkinson's disease.
D2 Receptors - (ANSWER)Primary binding site for dopamine agonists.
Mesocorticol Projections - (ANSWER)Pathways influencing cognitive symptoms in schizophrenia.
Fluoxetine - (ANSWER)Antidepressant with rare induction of mania.
MAO Inhibitors - (ANSWER)Medications requiring avoidance of certain decongestants.
Hypertensive Crisis - (ANSWER)Severe increase in blood pressure from drug interactions.
Residual Symptoms - (ANSWER)Symptoms persisting despite treatment for major depression.
SERT Genotype - (ANSWER)Influences response to SSRIs and SNRIs.
Anhedonia - (ANSWER)Inability to feel pleasure, common in depression.
Agitation - (ANSWER)Considered a positive symptom of schizophrenia.
Paranoid Psychosis - (ANSWER)Requires antipsychotics targeting specific symptoms.
Dopamine Hypothesis - (ANSWER)Theory explaining schizophrenia symptoms via dopamine pathways.
Noncompliance - (ANSWER)Patient refusal to follow prescribed treatment.
Neurotransmitter Imbalance - (ANSWER)Disruption in brain chemical levels affecting mood.
Positive Symptoms - (ANSWER)Symptoms that add to the patient's experience.
Agitation - (ANSWER)Increased restlessness or anxiety in schizophrenia.
Serotonin - (ANSWER)Neurotransmitter linked to mood regulation.
Prozac - (ANSWER)First antidepressant targeting serotonin imbalance.
Dysfunctioning Neurotransmitter Systems - (ANSWER)Impaired neurotransmitter functions in psychiatric
illnesses.
Gene Expression - (ANSWER)Process of converting genetic information into proteins.
Transcription Factor - (ANSWER)Protein that initiates gene transcription.
Behavior Modification - (ANSWER)Changes in behavior influencing genetic expression.
Cytochrome P450 - (ANSWER)Enzyme system affecting drug metabolism.
Bioavailability - (ANSWER)Amount of drug available after metabolism.
Pharmacokinetics - (ANSWER)Study of drug absorption, distribution, metabolism, and excretion.
Lower Drug Doses - (ANSWER)Some Asians require reduced doses of medications.
,NURS 6630 MIDTERM EXAM QUESTIONS AND ANSWERS 2025
G-Protein Linked Receptors - (ANSWER)Receptors that mediate cellular responses to neurotransmitters.
Antagonistic Traits - (ANSWER)Medications that block receptor activity.
Clozapine (Clozaril) - (ANSWER)Medication used for treatment-resistant schizophrenia.
Smoking Impact - (ANSWER)Smoking can alter medication metabolism.
Carbamazepine (Tegretol) - (ANSWER)Mood stabilizer associated with thrombocytopenia.
Mood Stabilizer - (ANSWER)Medication used to treat mood disorders.
Amitriptyline (Elavil) - (ANSWER)Antidepressant also used for chronic pain.
Fluoxetine (Prozac) - (ANSWER)SSRI antidepressant for depression and anxiety.
Drug-Induced Thrombocytopenia - (ANSWER)Low platelet count caused by medication.
Amitriptyline (Elavil) - (ANSWER)An antidepressant used for mood disorders.
Inverse agonist - (ANSWER)Decreases serotonin and dopamine activity.
Benzodiazepines - (ANSWER)Medications for anxiety and panic disorders.
Ionotropic receptors - (ANSWER)Receptors that mediate rapid synaptic transmission.
Varenicline (Chantix) - (ANSWER)Medication used for smoking cessation.
,NURS 6630 MIDTERM EXAM QUESTIONS AND ANSWERS 2025
Partial agonists - (ANSWER)Drugs that partially stimulate receptors.
Anticonvulsants - (ANSWER)Medications used to stabilize mood and treat seizures.
Ligand-gated ion channels - (ANSWER)Channels activated by neurotransmitter binding.
Sertraline - (ANSWER)An SSRI used to treat panic disorder.
Short-acting benzodiazepine - (ANSWER)Used temporarily to manage anxiety symptoms.
Mood stabilizers - (ANSWER)Medications that prevent mood swings in bipolar disorder.
MAO inhibitors - (ANSWER)Antidepressants with significant food interactions.
Fluoxetine - (ANSWER)An SSRI with uncommon sedation side effects.
Manic symptoms - (ANSWER)Signs of elevated mood and hyperactivity.
D2 receptors - (ANSWER)Dopamine receptors targeted by antipsychotics.
Tardive dyskinesia - (ANSWER)Involuntary movements from long-term antipsychotic use.
Hypertensive crisis - (ANSWER)Severe increase in blood pressure from food interactions.
Serotonin 3 receptors - (ANSWER)Receptors involved in serotonin signaling.
Nicotinic receptors - (ANSWER)Cholinergic receptors that respond to acetylcholine.
, NURS 6630 MIDTERM EXAM QUESTIONS AND ANSWERS 2025
Cholinergic receptors - (ANSWER)Receptors activated by the neurotransmitter acetylcholine.
Glycine receptors - (ANSWER)Inhibitory receptors in the central nervous system.
Dopamine agonist - (ANSWER)Stimulates dopamine receptors to treat Parkinson's disease.
D2 Receptors - (ANSWER)Primary binding site for dopamine agonists.
Mesocorticol Projections - (ANSWER)Pathways influencing cognitive symptoms in schizophrenia.
Fluoxetine - (ANSWER)Antidepressant with rare induction of mania.
MAO Inhibitors - (ANSWER)Medications requiring avoidance of certain decongestants.
Hypertensive Crisis - (ANSWER)Severe increase in blood pressure from drug interactions.
Residual Symptoms - (ANSWER)Symptoms persisting despite treatment for major depression.
SERT Genotype - (ANSWER)Influences response to SSRIs and SNRIs.
Anhedonia - (ANSWER)Inability to feel pleasure, common in depression.
Agitation - (ANSWER)Considered a positive symptom of schizophrenia.
Paranoid Psychosis - (ANSWER)Requires antipsychotics targeting specific symptoms.
Dopamine Hypothesis - (ANSWER)Theory explaining schizophrenia symptoms via dopamine pathways.
